BC Platforms

company

About

BC Platforms is a data and technology company providing tools to advance the development of personalized medicine and precision medicine.

Details

Last Funding Type
Private Equity(PE)
Last Funding Money Raised
Fr20M
Industries
Analytics,Health Care,Life Science,Pharmaceutical,Software
Founded date
Jan 1, 1997
Number Of Employee
51 - 100
Operating Status
Active
Legal Name
BC Platforms Ltd

BCP provides a unique data and technology platform to enable life sciences and healthcare companies to access, manage and analyze clinical and omics data. BCP’s Data Access Platform provides access and related technology to valuable data (RWD, Clinical, Genomics, and Omics) for the Life Science Industry. The Company’s Data Partner Network currently covers more than 22m life-years of highly curated patient data from around the world and is steadily growing. These data are made accessible to Pharma companies through a data-as-a-service (DaaS) model. BCP is able to provide Life Science companies with transformational capabilities to access longitudinal clinical and genome data across the globe to enhance different use cases within the R&D continuum, speeding up the process from early discovery to clinical and post-market access processes. BCP’s technology platform provides technology to Healthcare Providers and Life Science companies to produce, manage and analyze complex genomics as a clinical decision-support solution, analyze the data (genomics- omics and clinical) and make it available for any research ensuring compatibility with all relevant technical standards and in compliance with local privacy law in different jurisdictions.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
Fr20M $25M
BC Platforms has raised a total of Fr20M $25M in funding over 2 rounds. Their latest funding was raised on Nov 8, 2022 from a Private Equity(PE) round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 8, 2022 Private Equity(PE) Fr20M 1 Jolt Capital Detail
Dec 18, 2019 Series C $15M 3 IQVIA Detail
May 9, 2017 Series B $10M 2 Debiopharm Innovation Fund
Tesi
Detail
Nov 24, 2016 Series Unknown 1 Boston Millennia Partners Detail

Investors

Number of Lead Investors
Number of Investors
5
5
BC Platforms is funded by 5 investors. Jolt Capital and IQVIA are the most recent investors.
Investor Name Lead Investor Funding Round
Jolt Capital Yes Private Equity(PE)
IQVIA Yes Series C
Boston Millennia Partners Yes Series Unknown
Debiopharm Innovation Fund Series C
Tesi Series C

Employee Profiles

Number of Employee Profiles
10
BC Platforms has 10 current employee profiles, including Board member Richard Kivel
Board member
Board member
Executive
Executive
Employee